EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The role of vaginal progesterone for preterm birth prevention in women with threatened labor and shortened cervix diagnosed after 24 weeks of pregnancy

Doron Kabiri iD, Dror Raif Nesher, Danielle Luxenbourg, Amihai Rottenstreich, Joshua I Rosenbloom, Yosef Ezra, Simcha Yagel, Shay Porat, Roberto Romero

International Journal of Gynecology & Obstetrics · 2023-05 · 161 (2) · 423-431

DOI: 10.1002/ijgo.14465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 26.09.2022. Verfasst von Doron Kabiri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Premature Birth, Obstetric Labor, Premature. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, Intramural NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine whether vaginal progesterone treatment for women with a short cervix, diagnosed after 24 weeks of pregnancy, reduces preterm birth rates.

Methods

A retrospective cohort study that included women with a singleton pregnancy, threatened preterm labor, and a short cervix measured between 24 +0 and 33 +6 weeks. Women who received vaginal progesterone were compared with women who did not receive progesterone. The primary outcome was spontaneous preterm birth before 37 weeks of pregnancy.

Results

Patients who received vaginal progesterone had a lower rate of preterm delivery at less than 37 weeks of pregnancy (18.2% [22/121] versus 28.9% [73/253]; adjusted hazard ratio 0.50; 95% confidence interval 0.28–0.73, P = 0.001). The diagnosis‐to‐delivery interval was significantly greater in patients who received progesterone than in those who did not—median time to delivery in weeks: 8.2 (interquartile range [IQR] 6.2–9.8) versus 6.6 (4.8–8.8), ( P < 0.001). The frequency of neonatal intensive care unit admission was significantly lower in patients who received progesterone than in those who did not (8.3% [10/121] versus 16.2% [41/253], P = 0.04).

Conclusions

The administration of vaginal progesterone to patients with an episode of threatened premature labor and a short cervix presenting after 24 weeks of pregnancy was associated with lower rates of premature births.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthObstetric Labor, PrematurePregnancyInfant, NewbornHumansFemaleProgesteroneProgestinsCervix UteriRetrospective StudiesAdministration, Intravaginal

Stichwörter der Autor:innen

prematuritypreterm deliverypreterm laborprogesteroneprogestogenshort cervixsingleton pregnancytransvaginal ultrasound

Substanzen

ProgesteroneProgestins

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of…
  • Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, Michigan, USA.
  • Center for Molecular Medicine and Genetics, Wayne State University, Detroit, Michigan, USA.
  • Detroit Medical Center, Detroit, Michigan, USA.

ORCID-Profile: Doron Kabiri

Förderung

  • NICHD NIH HHS
  • Intramural NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

Kabiri, D., Raif Nesher, D., Luxenbourg, D., Rottenstreich, A., Rosenbloom, J. I., Ezra, Y., Yagel, S., Porat, S., & Romero, R. (2023). The role of vaginal progesterone for preterm birth prevention in women with threatened labor and shortened cervix diagnosed after 24 weeks of pregnancy. International Journal of Gynecology & Obstetrics, 161(2), 423-431. https://doi.org/10.1002/ijgo.14465

Vancouver

Kabiri D, Raif Nesher D, Luxenbourg D, Rottenstreich A, Rosenbloom JI, Ezra Y, et al. The role of vaginal progesterone for preterm birth prevention in women with threatened labor and shortened cervix diagnosed after 24 weeks of pregnancy. International Journal of Gynecology & Obstetrics. 2023;161(2):423-431. doi:10.1002/ijgo.14465

BibTeX
@article{Kabiri2023,
  author = {Kabiri, Doron and Raif Nesher, Dror and Luxenbourg, Danielle and Rottenstreich, Amihai and Rosenbloom, Joshua I and Ezra, Yosef and Yagel, Simcha and Porat, Shay and Romero, Roberto},
  title = {The role of vaginal progesterone for preterm birth prevention in women with threatened labor and shortened cervix diagnosed after 24 weeks of pregnancy},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2023},
  volume = {161},
  number = {2},
  pages = {423--431},
  doi = {10.1002/ijgo.14465}
}
Kostenlos starten →